Page 156 - 2021_06-Haematologica-web

M. Xie et al. 2013;495(7440):231-235.
42. Greenbaum A, Hsu YM, Day RB, et al. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature. 2013;495(7440):227- 230.
43. Tzeng YS, Li H, Kang YL, Chen WC, Cheng WC, Lai DM. Loss of Cxcl12/Sdf-1 in adult mice decreases the quiescent state of hematopoietic stem/progenitor cells and alters the pattern of hematopoietic regener- ation after myelosuppression. Blood. 2011;117(2):429-439.
CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest. 2003;111(2):187-196.
45. Broxmeyer HE, Orschell CM, Clapp DW, et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med. 2005;201(8):1307-1318.
46. Burns JM, Summers BC, Wang Y, et al. A novel chemokine receptor for SDF-1 and I- TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med. 2006;203(9):2201-2213.
47. Ogawa M. Differentiation and proliferation
of hematopoietic stem cells. Blood.
1993;81(11):2844-2853.
48. Adolfsson J, Månsson R, Buza-Vidas N, et al.
Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic Potential. Cell. 2005;121(2):295-306.
49. Saito Y, Uchida N, Tanaka S, et al. Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. Nat Biotechnol. 2010;28(3):275-280.
50. Lowenberg B, van Putten W, Theobald M, et al. Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. N Engl J Med. 2003;349(8):743-752.
44.
Lévesque J-P, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ. Disruption of the
1658
haematologica | 2021; 106(6)